Global Recombinant Human Interleukin-2 for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Recombinant Human Interleukin-2 for Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body's immune system.

Recombinant Human Interleukin-2 for Injection holds a significant presence in the biopharmaceutical market with promising prospects. The market continues to expand, driven by the growing field of cancer immunotherapy and the autoimmune disease treatment market. Specific uses include cancer immunotherapy, immunosuppression post-organ transplantation, and treatment of various immunological disorders. The future development outlook is positive, with ongoing advancements in biotechnology potentially leading to additional therapeutic indications and improved formulation options to meet the increasing demand from patients.

The Global Info Research report includes an overview of the development of the Recombinant Human Interleukin-2 for Injection industry chain, the market status of Hospital (50000 IU, 100000 IU), Pharmacy (50000 IU, 100000 IU), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Human Interleukin-2 for Injection.

Regionally, the report analyzes the Recombinant Human Interleukin-2 for Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Human Interleukin-2 for Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Recombinant Human Interleukin-2 for Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Human Interleukin-2 for Injection industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 50000 IU, 100000 IU).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Human Interleukin-2 for Injection market.

Regional Analysis: The report involves examining the Recombinant Human Interleukin-2 for Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Human Interleukin-2 for Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Recombinant Human Interleukin-2 for Injection:
Company Analysis: Report covers individual Recombinant Human Interleukin-2 for Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Human Interleukin-2 for Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Recombinant Human Interleukin-2 for Injection. It assesses the current state, advancements, and potential future developments in Recombinant Human Interleukin-2 for Injection areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Human Interleukin-2 for Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Recombinant Human Interleukin-2 for Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    50000 IU
    100000 IU
    200000 IU
    500000 IU
    1 Million IU

Market segment by Application
    Hospital
    Pharmacy

Major players covered
    Clinigen
    3SBio
    Beijing Four Rings Biopharmaceutical
    Jiangsu Kingsley Pharmaceutical
    Beijing Yuance Pharmaceutical
    Beijing SL Pharm
    Shanghai Huaxin Biotechnology
    Changchun Institute Of Biological Products
    Shandong Quangang Pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Interleukin-2 for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Interleukin-2 for Injection, with price, sales, revenue and global market share of Recombinant Human Interleukin-2 for Injection from 2019 to 2024.
Chapter 3, the Recombinant Human Interleukin-2 for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Interleukin-2 for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Recombinant Human Interleukin-2 for Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Interleukin-2 for Injection.
Chapter 14 and 15, to describe Recombinant Human Interleukin-2 for Injection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Human Interleukin-2 for Injection
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Recombinant Human Interleukin-2 for Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 50000 IU
        1.3.3 100000 IU
        1.3.4 200000 IU
        1.3.5 500000 IU
        1.3.6 1 Million IU
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Recombinant Human Interleukin-2 for Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Pharmacy
    1.5 Global Recombinant Human Interleukin-2 for Injection Market Size & Forecast
        1.5.1 Global Recombinant Human Interleukin-2 for Injection Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Recombinant Human Interleukin-2 for Injection Sales Quantity (2019-2030)
        1.5.3 Global Recombinant Human Interleukin-2 for Injection Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Clinigen
        2.1.1 Clinigen Details
        2.1.2 Clinigen Major Business
        2.1.3 Clinigen Recombinant Human Interleukin-2 for Injection Product and Services
        2.1.4 Clinigen Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Clinigen Recent Developments/Updates
    2.2 3SBio
        2.2.1 3SBio Details
        2.2.2 3SBio Major Business
        2.2.3 3SBio Recombinant Human Interleukin-2 for Injection Product and Services
        2.2.4 3SBio Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 3SBio Recent Developments/Updates
    2.3 Beijing Four Rings Biopharmaceutical
        2.3.1 Beijing Four Rings Biopharmaceutical Details
        2.3.2 Beijing Four Rings Biopharmaceutical Major Business
        2.3.3 Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
        2.3.4 Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Beijing Four Rings Biopharmaceutical Recent Developments/Updates
    2.4 Jiangsu Kingsley Pharmaceutical
        2.4.1 Jiangsu Kingsley Pharmaceutical Details
        2.4.2 Jiangsu Kingsley Pharmaceutical Major Business
        2.4.3 Jiangsu Kingsley Pharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
        2.4.4 Jiangsu Kingsley Pharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
    2.5 Beijing Yuance Pharmaceutical
        2.5.1 Beijing Yuance Pharmaceutical Details
        2.5.2 Beijing Yuance Pharmaceutical Major Business
        2.5.3 Beijing Yuance Pharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
        2.5.4 Beijing Yuance Pharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Beijing Yuance Pharmaceutical Recent Developments/Updates
    2.6 Beijing SL Pharm
        2.6.1 Beijing SL Pharm Details
        2.6.2 Beijing SL Pharm Major Business
        2.6.3 Beijing SL Pharm Recombinant Human Interleukin-2 for Injection Product and Services
        2.6.4 Beijing SL Pharm Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Beijing SL Pharm Recent Developments/Updates
    2.7 Shanghai Huaxin Biotechnology
        2.7.1 Shanghai Huaxin Biotechnology Details
        2.7.2 Shanghai Huaxin Biotechnology Major Business
        2.7.3 Shanghai Huaxin Biotechnology Recombinant Human Interleukin-2 for Injection Product and Services
        2.7.4 Shanghai Huaxin Biotechnology Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Shanghai Huaxin Biotechnology Recent Developments/Updates
    2.8 Changchun Institute Of Biological Products
        2.8.1 Changchun Institute Of Biological Products Details
        2.8.2 Changchun Institute Of Biological Products Major Business
        2.8.3 Changchun Institute Of Biological Products Recombinant Human Interleukin-2 for Injection Product and Services
        2.8.4 Changchun Institute Of Biological Products Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Changchun Institute Of Biological Products Recent Developments/Updates
    2.9 Shandong Quangang Pharmaceutical
        2.9.1 Shandong Quangang Pharmaceutical Details
        2.9.2 Shandong Quangang Pharmaceutical Major Business
        2.9.3 Shandong Quangang Pharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
        2.9.4 Shandong Quangang Pharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Shandong Quangang Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Recombinant Human Interleukin-2 for Injection by Manufacturer
    3.1 Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Recombinant Human Interleukin-2 for Injection Revenue by Manufacturer (2019-2024)
    3.3 Global Recombinant Human Interleukin-2 for Injection Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Recombinant Human Interleukin-2 for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Recombinant Human Interleukin-2 for Injection Manufacturer Market Share in 2023
        3.4.2 Top 6 Recombinant Human Interleukin-2 for Injection Manufacturer Market Share in 2023
    3.5 Recombinant Human Interleukin-2 for Injection Market: Overall Company Footprint Analysis
        3.5.1 Recombinant Human Interleukin-2 for Injection Market: Region Footprint
        3.5.2 Recombinant Human Interleukin-2 for Injection Market: Company Product Type Footprint
        3.5.3 Recombinant Human Interleukin-2 for Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Recombinant Human Interleukin-2 for Injection Market Size by Region
        4.1.1 Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2019-2030)
        4.1.2 Global Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2019-2030)
        4.1.3 Global Recombinant Human Interleukin-2 for Injection Average Price by Region (2019-2030)
    4.2 North America Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030)
    4.3 Europe Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030)
    4.4 Asia-Pacific Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030)
    4.5 South America Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030)
    4.6 Middle East and Africa Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2030)
    5.2 Global Recombinant Human Interleukin-2 for Injection Consumption Value by Type (2019-2030)
    5.3 Global Recombinant Human Interleukin-2 for Injection Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2030)
    6.2 Global Recombinant Human Interleukin-2 for Injection Consumption Value by Application (2019-2030)
    6.3 Global Recombinant Human Interleukin-2 for Injection Average Price by Application (2019-2030)

7 North America
    7.1 North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2030)
    7.2 North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2030)
    7.3 North America Recombinant Human Interleukin-2 for Injection Market Size by Country
        7.3.1 North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2030)
        7.3.2 North America Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2030)
    8.2 Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2030)
    8.3 Europe Recombinant Human Interleukin-2 for Injection Market Size by Country
        8.3.1 Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2030)
        8.3.2 Europe Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Recombinant Human Interleukin-2 for Injection Market Size by Region
        9.3.1 Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2030)
    10.2 South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2030)
    10.3 South America Recombinant Human Interleukin-2 for Injection Market Size by Country
        10.3.1 South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2030)
        10.3.2 South America Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Recombinant Human Interleukin-2 for Injection Market Size by Country
        11.3.1 Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Recombinant Human Interleukin-2 for Injection Market Drivers
    12.2 Recombinant Human Interleukin-2 for Injection Market Restraints
    12.3 Recombinant Human Interleukin-2 for Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Recombinant Human Interleukin-2 for Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Recombinant Human Interleukin-2 for Injection
    13.3 Recombinant Human Interleukin-2 for Injection Production Process
    13.4 Recombinant Human Interleukin-2 for Injection Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Recombinant Human Interleukin-2 for Injection Typical Distributors
    14.3 Recombinant Human Interleukin-2 for Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Clinigen Basic Information, Manufacturing Base and Competitors
    Table 4. Clinigen Major Business
    Table 5. Clinigen Recombinant Human Interleukin-2 for Injection Product and Services
    Table 6. Clinigen Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Clinigen Recent Developments/Updates
    Table 8. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 9. 3SBio Major Business
    Table 10. 3SBio Recombinant Human Interleukin-2 for Injection Product and Services
    Table 11. 3SBio Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. 3SBio Recent Developments/Updates
    Table 13. Beijing Four Rings Biopharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 14. Beijing Four Rings Biopharmaceutical Major Business
    Table 15. Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
    Table 16. Beijing Four Rings Biopharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Beijing Four Rings Biopharmaceutical Recent Developments/Updates
    Table 18. Jiangsu Kingsley Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 19. Jiangsu Kingsley Pharmaceutical Major Business
    Table 20. Jiangsu Kingsley Pharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
    Table 21. Jiangsu Kingsley Pharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Jiangsu Kingsley Pharmaceutical Recent Developments/Updates
    Table 23. Beijing Yuance Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 24. Beijing Yuance Pharmaceutical Major Business
    Table 25. Beijing Yuance Pharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
    Table 26. Beijing Yuance Pharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Beijing Yuance Pharmaceutical Recent Developments/Updates
    Table 28. Beijing SL Pharm Basic Information, Manufacturing Base and Competitors
    Table 29. Beijing SL Pharm Major Business
    Table 30. Beijing SL Pharm Recombinant Human Interleukin-2 for Injection Product and Services
    Table 31. Beijing SL Pharm Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Beijing SL Pharm Recent Developments/Updates
    Table 33. Shanghai Huaxin Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 34. Shanghai Huaxin Biotechnology Major Business
    Table 35. Shanghai Huaxin Biotechnology Recombinant Human Interleukin-2 for Injection Product and Services
    Table 36. Shanghai Huaxin Biotechnology Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Shanghai Huaxin Biotechnology Recent Developments/Updates
    Table 38. Changchun Institute Of Biological Products Basic Information, Manufacturing Base and Competitors
    Table 39. Changchun Institute Of Biological Products Major Business
    Table 40. Changchun Institute Of Biological Products Recombinant Human Interleukin-2 for Injection Product and Services
    Table 41. Changchun Institute Of Biological Products Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Changchun Institute Of Biological Products Recent Developments/Updates
    Table 43. Shandong Quangang Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 44. Shandong Quangang Pharmaceutical Major Business
    Table 45. Shandong Quangang Pharmaceutical Recombinant Human Interleukin-2 for Injection Product and Services
    Table 46. Shandong Quangang Pharmaceutical Recombinant Human Interleukin-2 for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Shandong Quangang Pharmaceutical Recent Developments/Updates
    Table 48. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 49. Global Recombinant Human Interleukin-2 for Injection Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Recombinant Human Interleukin-2 for Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 51. Market Position of Manufacturers in Recombinant Human Interleukin-2 for Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Recombinant Human Interleukin-2 for Injection Production Site of Key Manufacturer
    Table 53. Recombinant Human Interleukin-2 for Injection Market: Company Product Type Footprint
    Table 54. Recombinant Human Interleukin-2 for Injection Market: Company Product Application Footprint
    Table 55. Recombinant Human Interleukin-2 for Injection New Market Entrants and Barriers to Market Entry
    Table 56. Recombinant Human Interleukin-2 for Injection Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2019-2024) & (K Units)
    Table 58. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2025-2030) & (K Units)
    Table 59. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Recombinant Human Interleukin-2 for Injection Average Price by Region (2019-2024) & (US$/Unit)
    Table 62. Global Recombinant Human Interleukin-2 for Injection Average Price by Region (2025-2030) & (US$/Unit)
    Table 63. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 64. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 65. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Recombinant Human Interleukin-2 for Injection Average Price by Type (2019-2024) & (US$/Unit)
    Table 68. Global Recombinant Human Interleukin-2 for Injection Average Price by Type (2025-2030) & (US$/Unit)
    Table 69. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 70. Global Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 71. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Recombinant Human Interleukin-2 for Injection Average Price by Application (2019-2024) & (US$/Unit)
    Table 74. Global Recombinant Human Interleukin-2 for Injection Average Price by Application (2025-2030) & (US$/Unit)
    Table 75. North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 76. North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 77. North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 78. North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 79. North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2024) & (K Units)
    Table 80. North America Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2025-2030) & (K Units)
    Table 81. North America Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 84. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 85. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 86. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 87. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2024) & (K Units)
    Table 88. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2025-2030) & (K Units)
    Table 89. Europe Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 92. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 93. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 94. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 95. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2019-2024) & (K Units)
    Table 96. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2025-2030) & (K Units)
    Table 97. Asia-Pacific Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 100. South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 101. South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 102. South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 103. South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2019-2024) & (K Units)
    Table 104. South America Recombinant Human Interleukin-2 for Injection Sales Quantity by Country (2025-2030) & (K Units)
    Table 105. South America Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Recombinant Human Interleukin-2 for Injection Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2019-2024) & (K Units)
    Table 108. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Type (2025-2030) & (K Units)
    Table 109. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2019-2024) & (K Units)
    Table 110. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Application (2025-2030) & (K Units)
    Table 111. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2019-2024) & (K Units)
    Table 112. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity by Region (2025-2030) & (K Units)
    Table 113. Middle East & Africa Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Recombinant Human Interleukin-2 for Injection Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Recombinant Human Interleukin-2 for Injection Raw Material
    Table 116. Key Manufacturers of Recombinant Human Interleukin-2 for Injection Raw Materials
    Table 117. Recombinant Human Interleukin-2 for Injection Typical Distributors
    Table 118. Recombinant Human Interleukin-2 for Injection Typical Customers
List of Figures
    Figure 1. Recombinant Human Interleukin-2 for Injection Picture
    Figure 2. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Type in 2023
    Figure 4. 50000 IU Examples
    Figure 5. 100000 IU Examples
    Figure 6. 200000 IU Examples
    Figure 7. 500000 IU Examples
    Figure 8. 1 Million IU Examples
    Figure 9. Global Recombinant Human Interleukin-2 for Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 10. Global Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Application in 2023
    Figure 11. Hospital Examples
    Figure 12. Pharmacy Examples
    Figure 13. Global Recombinant Human Interleukin-2 for Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Recombinant Human Interleukin-2 for Injection Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Recombinant Human Interleukin-2 for Injection Sales Quantity (2019-2030) & (K Units)
    Figure 16. Global Recombinant Human Interleukin-2 for Injection Average Price (2019-2030) & (US$/Unit)
    Figure 17. Global Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Recombinant Human Interleukin-2 for Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Recombinant Human Interleukin-2 for Injection Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Recombinant Human Interleukin-2 for Injection Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Recombinant Human Interleukin-2 for Injection Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Recombinant Human Interleukin-2 for Injection Average Price by Type (2019-2030) & (US$/Unit)
    Figure 32. Global Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Recombinant Human Interleukin-2 for Injection Average Price by Application (2019-2030) & (US$/Unit)
    Figure 35. North America Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Recombinant Human Interleukin-2 for Injection Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Recombinant Human Interleukin-2 for Injection Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Recombinant Human Interleukin-2 for Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Recombinant Human Interleukin-2 for Injection Market Drivers
    Figure 76. Recombinant Human Interleukin-2 for Injection Market Restraints
    Figure 77. Recombinant Human Interleukin-2 for Injection Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Recombinant Human Interleukin-2 for Injection in 2023
    Figure 80. Manufacturing Process Analysis of Recombinant Human Interleukin-2 for Injection
    Figure 81. Recombinant Human Interleukin-2 for Injection Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical